ramatroban has been researched along with ridogrel in 1 studies
| Studies (ramatroban) | Trials (ramatroban) | Recent Studies (post-2010) (ramatroban) | Studies (ridogrel) | Trials (ridogrel) | Recent Studies (post-2010) (ridogrel) |
|---|---|---|---|---|---|
| 142 | 10 | 28 | 90 | 10 | 1 |
| Protein | Taxonomy | ramatroban (IC50) | ridogrel (IC50) |
|---|---|---|---|
| Thromboxane A2 receptor | Homo sapiens (human) | 2.48 | |
| Thromboxane-A synthase | Homo sapiens (human) | 0.0062 | |
| Thromboxane-A synthase | Rattus norvegicus (Norway rat) | 0.006 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bacon, KB; Okano, M; Shichijo, M; Sugimoto, H | 1 |
1 other study(ies) available for ramatroban and ridogrel
| Article | Year |
|---|---|
CRTH2-specific binding characteristics of [3H]ramatroban and its effects on PGD2-, 15-deoxy-Delta12, 14-PGJ2- and indomethacin-induced agonist responses.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Binding, Competitive; Bridged Bicyclo Compounds, Heterocyclic; Calcium; Carbazoles; Cell Line; Cell Movement; Cyclic AMP; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Humans; Hydrazines; Indomethacin; Models, Biological; Pentanoic Acids; Prostaglandin D2; Pyridines; Receptors, Immunologic; Receptors, Prostaglandin; Sulfonamides; Transfection; Tritium | 2005 |